🇺🇸 FDA
Patent

US 11976274

Methods and compositions for identifying neoantigens for use in treating and preventing cancer

granted A61KA61K38/08A61K38/10

Quick answer

US patent 11976274 (Methods and compositions for identifying neoantigens for use in treating and preventing cancer) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K38/08, A61K38/10, A61K38/16, A61K39/0011